Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MARCORODEX 1 G / 100 ML — DIN 02229710

PHENOXYETHANOL : 1 G / 100 ML BENZETHONIUM CHLORIDE : 0.13 G / 100 ML · ROUGIER PHARMA DIVISION OF RATIOPHARM INC · LIQUID · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is MARCORODEX?

MARCORODEX 1 G / 100 ML contains PHENOXYETHANOL : 1 G / 100 ML BENZETHONIUM CHLORIDE : 0.13 G / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 02229710, held by ROUGIER PHARMA DIVISION OF RATIOPHARM INC, supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

Is there a generic Benzethonium Chloride, Combinations in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

6 holders have a Canadian DIN containing Benzethonium Chloride, Combinations, across 7 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
VEXCO LABORATORIES INC.20LIPSOREX - GEL, LIPSOREX-GELNo marketed DIN
ARJO CANADA INC10ANTISEPTIC SKIN CREAMNo marketed DIN
CANDERM G.P.10LIPSOREXNo marketed DIN
GLAXOSMITHKLINE INC10BURO SOL ANTISEPTIC POWDERNo marketed DIN
MAHDEEN MEDICEUTICALS, DIVISION OF ZERON INC.10MRX LIQNo marketed DIN
ROUGIER PHARMA DIVISION OF RATIOPHARM INC10MARCORODEXNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label1 G / 100 ML
Dosage formLIQUID
RouteTOPICAL

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceBenzethonium Chloride, Combinations
ATC codeD08AJ58
AHFS class84:04.92
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02229710
DIN (unpadded, as printed on some documents)2229710
Brand nameMARCORODEX
Generic / active ingredientPHENOXYETHANOL : 1 G / 100 ML BENZETHONIUM CHLORIDE : 0.13 G / 100 ML
Market authorization holderROUGIER PHARMA DIVISION OF RATIOPHARM INC
Health Canada scheduleNON-PRESCRIPTION DRUGS
ATC codeD08AJ58
ATC anatomical main groupD — Dermatologicals
ATC therapeutic subgroupD08AJ
Current statusCANCELLED POST MARKET
Status date04-Aug-2009
Original market date1996-12-10 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

0 of 7 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
ANTISEPTIC SKIN CREAM2000 UNITCREAMARJO CANADA INCCANCELLED POST MARKET01988158
BURO SOL ANTISEPTIC POWDER0.35 %POWDERGLAXOSMITHKLINE INCCANCELLED POST MARKET00579947
LIPSOREX0.26 %GELCANDERM G.P.CANCELLED POST MARKET02237806
LIPSOREX - GEL0.9 %GELVEXCO LABORATORIES INC.CANCELLED POST MARKET02122006
LIPSOREX-GEL0.9 %GELVEXCO LABORATORIES INC.CANCELLED POST MARKET02138239
MRX LIQ0.2 %LIQUIDMAHDEEN MEDICEUTICALS, DIVISION OF ZERON INC.CANCELLED POST MARKET00430765

2 · Same class — other molecules in ATC D08AJ

MoleculeCanadian brandsDINsMarketedSourceable
BenzalkoniumACCLAIM AB · ADVANTAGE SANITIZING WIPES · ALASKA NETTOYANT ANTISEPTIQUE POUR LES MAINS HAND SANITIZER · ALCOHOL FREE FOAMING HAND SANITIZER · +288 more31237Yes
Benzethonium ChlorideACCLAYM · ANTIBACTERIAL BENZETHONIUM CHLORIDE HAND WIPES · ANTISEPTIC CLEANSER LIQ 0.14% · ANTISEPTIC SKIN CREAM - 1MG/G · +41 more453Yes
CetrimoniumCETRIMIDE AQUEOUS SOLN 1% · CETRIMIDE CREAM 0.5% · CETRIMIDE TINCTURE 0.5%32Yes
Benzalkonium, CombinationsALL STAR ANTISEPTIC HAND SOAP E-2 · ANTI-BACTERIAL WATERLESS HAND FOAM · ANTISEPTIC SWABS 4MG/ML · AVON NAIL EXPERTS MIRA-CUTICLE ADVANCED MOISTURIZING VANISHING COMPLEX · +11 more160Not in Canada
Benzethonium Chloride, CombinationsANTISEPTIC SKIN CREAM · BURO SOL ANTISEPTIC POWDER · LIPSOREX · LIPSOREX - GEL · +3 more70Not in Canada
CetrimideSAVLON CRM 0.5%10Not in Canada
Quaternary Ammonium CompoundsDYMON ANTIBACTERIAL HAND SOAP WITH MOISTURIZERS10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC D08A

ATC subgroupMoleculesDINsMarketed
D08ACChlorhexidine · Chlorhexidine, Combinations · Hexamidine14333
D08AEChloroxylenol · Chloroxylenol, Combinations · Combinations, Of Phenol And Derivatives · Hexachlorophene · Metacresolsulphonic Acid-Formaldehyde · +2 more45816
D08ADBoric Acid Products70
D08ABAluminium Agents70
D08AGIodine · Iodine Products · Iodine, Combinations · Povidone-Iodine · Povidone-Iodine, Combinations500
D08AHClioquinol20
D08AXEthanol · Ethanol, Combinations · Hydrogen Peroxide · Isopropanol · Isopropanol, Combinations · +3 more1350

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02229710. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.